v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities    
Net Income / (loss) $ 35,202,000 $ 1,106,000
Adjustments to reconcile net income / (loss) to net cash used in operating activities:    
Depreciation and amortization expenses 174,000 54,000
Amortization of debt discount 1,532,000 1,178,000
Stock-based expenses 397,000 1,847,000
Impairment of fixed assets 16,000
Accretion of note discount 38,000
Gain on Deconsolidation of subsidiary (42,691,000)
Change in fair value of stock-based compensation (778,000)
Bad debt expense 383,000 317,000
Loss of debt extinguishment 110,000 192,000
Write-off of unamortized debt discount on conversion 313,000
Notes payable capitalized interest 57,000
Changes in operating assets and liabilities:    
Accounts receivable, net (26,439,000)
Notes receivable 668,000
Other current assets 62,000 57,676,000
Other non-current assets 10,000
Accounts payable and accrued expenses 2,425,000 6,520,000
Other current liabilities (45,457,000)
Other non-current liabilities 661,000
Operating right to use assets and lease liabilities, net 93,000
Deferred revenue (2,251,000)
Net cash (used in) / provided by operating activities (1,218,000) (5,367,000)
Net cash (used in) / provided by operating activities - discontinued operations 124,000
Cash Flows from Investing Activities    
Deconsolidation of subsidiary (271,000)
Net cash (used in) / provided by investing activities (271,000)
Net cash (used in) / provided by investing activities - discontinued operations
Cash Flows from Financing Activities    
Proceeds from notes payable 1,000,000 10,002,000
Proceeds from issuance of Series A Preferred Stock 145,000
Payment of debt issuance costs (10,000)
Repayments of notes payables (182,000) (6,024,000)
Net cash provided by financing activities 953,000 3,978,000
Net cash used in financing activities - discontinued operations (42,000)
Foreign exchange translation adjustment 7,000 (57,000)
Net (decrease) increase in cash, cash equivalents, and restricted cash (529,000) (1,364,000)
Cash – beginning of period 653,000 1,786,000
Cash – end of period 124,000 422,000
Supplemental Disclosures of Cash Flow Information:    
Cash paid for interest 16,000 3,399,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities    
Conversion of notes payable into common stock (3,675,000) (1,241,000)
Conversion of stock 3,675,000 1,241,000
Issuance of promissory note for acquisition of Anira TradeOS 5,000,000
Issuance of common stock for purchase option, Anat Attia 1,612,000
Issuance of Series B preferred stock and common stock for acquisition of Anira TradeOS $ 7,013,000